Automation Workflow for Compiling Integrated Summaries of Safety (ISS) and Efficacy (ISE)

Manual ISS/ISE compilation is a 6-8 week bottleneck of harmonizing data across dozens of studies, executing statistical analyses, and drafting cohesive narratives. A custom automation workflow eliminates this repetitive, high-risk labor by orchestrating specialized agents. These agents directly query clinical data warehouses (e.g., Medidata Rave, Oracle Clinical), execute predefined SAS or R programs, and draft initial narratives, pulling from a controlled medical lexicon. The operational upside is direct: compressing a critical path activity to days, reducing administrative FTEs, and minimizing errors in high-stakes evidence synthesis.

Implementation integrates with Veeva Vault or Documentum for document management, embedding approval gates and version control. The architecture requires robust validation checkpoints for data lineage and statistical output accuracy before medical review. Observability is built-in, tracking agent decisions, data sources, and reviewer changes to create a defensible audit trail for regulatory scrutiny. This turns a fragmented, expert-dependent process into a scheduled, repeatable operating model that directly improves submission predictability and quality.

This orchestration layer automates the 6-8 week manual bottleneck of harmonizing data across multiple clinical studies. The business value is direct: it reduces compilation time to days, cuts administrative FTE burden by ~70%, and creates a repeatable, audit-ready process for high-stakes submissions. The architecture is built to integrate with clinical data warehouses (e.g., Medidata Rave, Oracle Clinical), statistical environments (SAS, R), and document repositories (Veeva Vault), ensuring data integrity from source to submission.

Implementation involves deploying agents as containerized services, often using LangGraph or CrewAI for coordination. The Orchestrator manages the workflow state, invoking specialized agents for discrete tasks. Critical controls include predefined analysis execution, confidence scoring on narrative drafts, and mandatory routing to a human-in-the-loop medical review gate before finalization. Observability is built in via logging all agent decisions, data queries, and reviewer actions to a centralized audit trail for inspection readiness.

Phase 1 establishes the foundational data pipeline, connecting to clinical data warehouses (e.g., Medidata Rave, Oracle Clinical) and statistical computing environments (SAS, R). The initial focus is automating the extraction and harmonization of patient-level data and study-level results across multiple trials. This phase delivers immediate value by eliminating manual data pooling, reducing a core 2-3 week task to hours, and creating a clean, auditable data layer for all subsequent automation. Implementation uses containerized agents with strict version control and validation checkpoints.

Phase 2 introduces the orchestration layer, deploying specialized agents for predefined statistical analyses and narrative drafting. Using a framework like LangGraph, agents execute analysis scripts, populate summary tables and figures, and draft initial narrative sections based on templates and extracted data. This phase cuts the analysis and drafting timeline from weeks to days. Crucially, all outputs are routed through a human-in-the-loop review system integrated with platforms like Veeva Vault, where medical reviewers can approve, reject, or edit drafts with full change tracking before final document lock.

Automating ISS/ISE compilation introduces significant operational leverage but carries high consequence. The governance model must enforce medical review checkpoints, data provenance validation, and audit trails. Implementation begins with a sandbox environment mirroring the clinical data warehouse (e.g., Medidata Rave, Oracle Clinical) and document management system (e.g., Veeva Vault). A pilot focuses on a single, completed study to validate agent outputs against the manually produced summary, establishing baseline accuracy and building stakeholder confidence before scaling.

Rollout progresses through defined phases, each gated by medical and statistical sign-off. Phase 2 expands to a small cohort of studies, testing the system's ability to harmonize data across protocols. The final phase enables full portfolio automation, integrated with submission planning timelines in systems like Planisware. Continuous monitoring tracks data drift and model confidence, with low-confidence analyses automatically routed for human review. This controlled approach de-risks deployment while capturing the time-to-submission benefit.

The primary operational bottleneck is harmonizing patient-level data, lab values, and adverse events across dozens of study databases (e.g., Medidata Rave, Oracle Clinical) with varying formats and standards. A custom workflow must first orchestrate extract-transform-load (ETL) agents that map raw data to CDISC SDTM/ADaM standards, applying sponsor-specific rules and validating conformance. This upfront integration layer, often built with Apache Airflow or Prefect, eliminates weeks of manual programmer mapping and is the foundation for reliable downstream analysis and narrative generation.

Implementation requires robust controls. Each agent's output routes through a validation queue, where discrepancies in pooled analyses or derived endpoints are flagged for biostatistical review. The final narrative synthesis agent, using RAG over prior submissions and guidelines, drafts summaries that are then locked into a review system like Veeva Vault for structured medical, legal, and regulatory (MLR) approval. This governed, traceable flow reduces a 6-8 week process to days while preserving the auditability required for agency scrutiny.